HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast

Malignant adenomyoepithelioma (AME) of the breast is an exceptionally rare form of breast cancer, with a significant metastatic potential. Chemotherapy has been used in the management of advanced AME patients, however the majority of treatments are not effective. Recent studies report recurrent muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Bièche, Ivan, Coussy, Florence, El-Botty, Rania, Vacher, Sophie, Château-Joubert, Sophie, Dahmani, Ahmed, Montaudon, Elodie, Reyes, Cécile, Gentien, David, Reyal, Fabien, Ricci, Francesco, Nicolas, André, Marchio, Caterina, Vincent-Salomon, Anne, Laé, Marick, Marangoni, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424935/
https://www.ncbi.nlm.nih.gov/pubmed/34496925
http://dx.doi.org/10.1186/s13045-021-01158-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424935/
https://www.ncbi.nlm.nih.gov/pubmed/34496925
http://dx.doi.org/10.1186/s13045-021-01158-3

Ejemplares similares